Ling Xie
Director/Miembro de la Junta en LAEKNA, INC. .
Fortuna: 33 M $ al 30/04/2024
Perfil
Ling Xie is currently the Director at Laekna Therapeutics (Shanghai) Co., Ltd., the Executive Director & Senior Vice President at Laekna, Inc., and the Director at Laekna Pharmaceutical Shanghai Co. Ltd.
Ms. Xie completed their undergraduate degree at East China University of Political Science & Law in 2003.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
LAEKNA, INC.
10.67% | 30/06/2023 | 41 618 770 ( 10.67% ) | 33 M $ | 30/04/2024 |
Cargos activos de Ling Xie
| Empresas | Cargo | Inicio |
|---|---|---|
| LAEKNA, INC. | Director/Miembro de la Junta | 01/05/2018 |
Laekna Therapeutics (Shanghai) Co., Ltd.
 Laekna Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Laekna Therapeutics (Shanghai) Co. Ltd. focuses on drug discovery and development. The company was founded by Chris Xiangyang Lu in December 2016 and is headquartered in Shanghai, China. | Director/Miembro de la Junta | - |
| Laekna Pharmaceutical Shanghai Co. Ltd. | Director/Miembro de la Junta | - |
Formación de Ling Xie.
| East China University of Political Science & Law | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| LAEKNA, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Laekna Therapeutics (Shanghai) Co., Ltd.
Laekna Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Laekna Therapeutics (Shanghai) Co. Ltd. focuses on drug discovery and development. The company was founded by Chris Xiangyang Lu in December 2016 and is headquartered in Shanghai, China. | Health Technology |
| Laekna Pharmaceutical Shanghai Co. Ltd. |
- Bolsa de valores
- Insiders
- Ling Xie
